BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 29230639)

  • 1. Conserved peptides enhance immune efficiency of inactive vaccines against emerging avian influenza viruses in chicken.
    Xiao J; Zhang L; Wang Z; Xiang W; Lu P; Zhao Y; Han M; Ma A; Qi P; Wang M; Gao GF; Liu WJ
    Sci China Life Sci; 2017 Dec; 60(12):1340-1347. PubMed ID: 29230639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken.
    Liang J; Fu J; Kang H; Lin J; Yu Q; Yang Q
    Poult Sci; 2013 Oct; 92(10):2651-60. PubMed ID: 24046412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus.
    Hwang SD; Kim HS; Cho SW; Seo SH
    Vaccine; 2011 Mar; 29(11):2178-86. PubMed ID: 21172378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive regulation of humoral and innate immune responses induced by inactivated Avian Influenza Virus vaccine in broiler chickens.
    Abdallah F; Hassanin O
    Vet Res Commun; 2015 Dec; 39(4):211-6. PubMed ID: 26329833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens.
    Fu J; Liang J; Kang H; Lin J; Yu Q; Yang Q
    Poult Sci; 2013 Nov; 92(11):2866-75. PubMed ID: 24135589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickens.
    Li D; Xue M; Wang C; Wang J; Chen P
    Clin Vaccine Immunol; 2011 Sep; 18(9):1497-502. PubMed ID: 21795462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
    Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
    J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coimmunization with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H5N1 vaccine against heterologous virus.
    Zhang Z; Zhang J; Zhang J; Li Q; Miao P; Liu J; Li S; Huang J; Liao M; Fan H
    Vet Microbiol; 2017 May; 203():143-148. PubMed ID: 28619136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avian influenza virus vaccines containing Toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens.
    St Paul M; Brisbin JT; Barjesteh N; Villaneueva AI; Parvizi P; Read LR; Nagy E; Sharif S
    Viral Immunol; 2014 May; 27(4):160-6. PubMed ID: 24797722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Singh SM; Alkie TN; Hodgins DC; Nagy É; Shojadoost B; Sharif S
    Vaccine; 2015 Jul; 33(32):3947-52. PubMed ID: 26092309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from H5N1 virus.
    Sasaki T; Isoda N; Soda K; Sakamoto R; Saijo K; Hagiwara J; Kokumai N; Ohgitani T; Imamura T; Sawata A; Lin Z; Sakoda Y; Kida H
    Jpn J Vet Res; 2009 Feb; 56(4):189-98. PubMed ID: 19358446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
    Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
    Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
    Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
    Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of Recombinant Adenovirus Expressing GM-CSF with Inactivated H5N1 Avian Influenza Vaccine Increased the Immune Responses and Protective Efficacy Against a Wild Bird Source of H5N1 Challenge.
    Wang X; Wang X; Jia Y; Wang C; Tang Q; Han Q; Xiao S; Yang Z
    J Interferon Cytokine Res; 2017 Oct; 37(10):467-473. PubMed ID: 29028432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.